Request a Pilot
Press & media

BactoAI in the media.

Coverage of our work on antimicrobial resistance, plus a press kit and a direct media contact for journalists, event organisers, and partners.

In the media

Bringing the AMR conversation to national television.

BactoAI founder Samwel Elegwa joined KUTV Kenya’s Art & Culture Monday to talk about antimicrobial resistance and why faster, genome-driven diagnostics matter for patients, clinicians, and public health systems.

“AMR is not just a lab problem. It is a public health emergency that needs to be part of everyday conversation.”
SE
Samwel Elegwa
Founder & CEO, BactoAI
Samwel Elegwa with Hassan Lewa at the KUTV Kenya studio
Behind the scenes

Samwel with Hassan Lewa at the KUTV studio after the Art & Culture Monday interview.

On the ecosystem stage

Representing BactoAI at the BIK Ventures Hub pitch event.

In May 2026, Samwel Elegwa and William Otieno represented BactoAI at the BIK Ventures Hub startup pitch event at Kenyatta University, a landmark competition bringing together founders, investors, and industry leaders. The event was covered in print and on BIK’s YouTube channel.

Newspaper coverage of the BIK Ventures Hub startup pitch event at Kenyatta University
In print · 16 May 2026

Press coverage of the BIK Ventures Hub pitch event at Kenyatta University, where BactoAI took the stage among East Africa’s emerging startups.

Founder reflections

Samwel shares his feedback on the BIK Ventures experience and what it means for startups building in East Africa.

Watch BIK’s event coverage

BIK’s recap video features the event’s innovations, including BactoAI.

More mentions will be listed here as they are published. Writing about AMR in Kenya or East Africa? Get in touch. We're happy to share data, context, and expert comment.
Press kit

Everything you need to write about us.

Logo & wordmark

The BactoAI wordmark with the bacterial emblem, for use in articles and event material. Please keep clear space around it and don't recolour it.

Download logo (PNG)

Company one-pager

A concise overview of the platform, our validation approach, and current pilot opportunities. Available on request while we finalise the public version.

Request one-pager

Interviews & expert comment

Our founder and team are available for interviews and background briefings on antimicrobial resistance, genomic diagnostics, and health innovation in East Africa.

Request an interview
Company boilerplate

BactoAI is a Kenyan health-technology company building an AMR intelligence platform that predicts antimicrobial resistance directly from bacterial genomes, helping clinicians and laboratories reach the right treatment decision faster. The platform is built and owned by BactoAI as a company, combining biotechnology, software engineering, machine learning, operations, and partnerships expertise.

Media contact

Talk to the BactoAI team.

For interviews, event invitations, data requests, or fact-checking, email us directly. We usually reply within two working days.